Skip to main content
SpringerLink
Log in
Book cover

Psoriasis and Psoriatic Arthritis pp 36–45Cite as

Psoriatic Arthritis

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gladman DD (2002) Current concepts in psoriatic arthritis. Curr Opin Rheumatol 14: 361–366

    Article  PubMed  Google Scholar 

  2. Mease PJ (2003) Current treatment of psoriatic arthritis. Rheum Dis Clin N Am 29: 495–511

    Google Scholar 

  3. Krueger GG, et al. (1984) Psoriasis. J Am Acad Dermatol 11: 937–947

    Article  PubMed  CAS  Google Scholar 

  4. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis [comment]. J Clin Invest 98: 1878–1887

    Article  PubMed  CAS  Google Scholar 

  5. Ellis CN, et al. (1991) Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial [see comment]. N Engl J Med 324: 277–284

    Article  PubMed  CAS  Google Scholar 

  6. Murphy FP, et al. (1999) Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes. Arch Dermatol 135: 1495–1502

    Article  PubMed  CAS  Google Scholar 

  7. Gottlieb SL, et al. (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1: 442–447

    PubMed  CAS  Google Scholar 

  8. Lebwohl M, et al. (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis [see comment]. Arch Dermatol 139: 719–727

    Article  PubMed  CAS  Google Scholar 

  9. Abrams JR, et al. (1999) CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 103: 1243–1252

    PubMed  CAS  Google Scholar 

  10. Pitzalis C, et al. (1996) Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 39: 137–145

    PubMed  CAS  Google Scholar 

  11. Tassiulas I, et al. (1999) Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol 60: 479–491

    Article  PubMed  CAS  Google Scholar 

  12. Borgato L, et al. (2002) The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions. J Rheumatol 29: 1914–1919

    PubMed  CAS  Google Scholar 

  13. Winchester R (2003) Psoriatic arthritis, dermatology in general medicine. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) McGraw-Hill, New York, pp 428–429

    Google Scholar 

  14. Fyrand O (1979) Immunological studies on synovial joint membranes in psoriatic arthritis. Acta Derm Venereol Suppl 87: 15–20

    CAS  Google Scholar 

  15. Smith MD, et al. (1992) Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 24: 19–26

    PubMed  CAS  Google Scholar 

  16. Veale D, et al. (1993) Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 36: 893–900

    PubMed  CAS  Google Scholar 

  17. Costello PJ, et al. (2001) Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol 166: 2878–2886

    PubMed  CAS  Google Scholar 

  18. Curran SA, et al. (2004) Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol 172: 1935–1944

    PubMed  CAS  Google Scholar 

  19. Fassbender HG, Fassbender R (1992) Synovial characteristics of seronegative spondarthritides. Clin Investigator 70: 706

    CAS  Google Scholar 

  20. Espinoza LR, et al. (1982) Vascular changes in psoriatic synovium. A light and electron microscopic study. Arthritis Rheum 25: 677–684

    PubMed  CAS  Google Scholar 

  21. Reece RJ, et al. (1999) Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 42: 1481–1484

    Article  PubMed  CAS  Google Scholar 

  22. Dupont E, et al. (1998) Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis. J Cutan Med Surg 2: 146–152

    PubMed  CAS  Google Scholar 

  23. Fearon U, et al. (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30: 260–268

    PubMed  CAS  Google Scholar 

  24. Ritchlin C, et al. (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25: 1544–1552

    PubMed  CAS  Google Scholar 

  25. Austin LM, et al. (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113: 752–759

    Article  PubMed  CAS  Google Scholar 

  26. Vervoordeldonk MJ, Tak PP (2002) Cytokines in rheumatoid arthritis. Curr Rheumatol Rep 4: 208–217

    PubMed  Google Scholar 

  27. Danning CL, et al. (2000) Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43: 1244–1256

    Article  PubMed  CAS  Google Scholar 

  28. Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266: 7313–7316

    PubMed  CAS  Google Scholar 

  29. Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334: 1717–1725

    Article  PubMed  CAS  Google Scholar 

  30. Brennan FM, Feldmann M (1992) Cytokines in autoimmunity. Curr Opin Immunol 4: 754–759

    Article  PubMed  CAS  Google Scholar 

  31. Saxne T, et al. (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31: 1041–1045

    PubMed  CAS  Google Scholar 

  32. Smith CA, et al. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019–1023

    PubMed  CAS  Google Scholar 

  33. Mohler KM, et al. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151: 1548–1561

    PubMed  CAS  Google Scholar 

  34. Sfikakis PP, Kollias G (2003) Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 15: 380–386

    Article  PubMed  CAS  Google Scholar 

  35. Redlich K, et al. (2004) Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum 50: 1001–1005

    Article  PubMed  CAS  Google Scholar 

  36. Baeten D, et al. (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study [comment]. Arthritis Rheum 44: 186–195

    PubMed  CAS  Google Scholar 

  37. Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3: 55–78

    Article  PubMed  CAS  Google Scholar 

  38. Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 199: 503–526

    Article  PubMed  CAS  Google Scholar 

  39. McGonagle D, et al. (1998) Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy [comment]. Arthritis Rheum 41: 694–700

    Article  PubMed  CAS  Google Scholar 

  40. Laloux L, et al. (2001) Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 60: 316–321

    Article  PubMed  CAS  Google Scholar 

  41. Marzo-Ortega H, et al. (2001) Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study [comment]. Arthritis Rheum 44: 2112–2117

    Article  PubMed  CAS  Google Scholar 

  42. Ribbens C, et al. (2002) Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61: 161–166

    Article  PubMed  CAS  Google Scholar 

  43. Vandooren B, et al. (2004) Matrix metalloproteinases and their inhibitors are involved in peripheral synovitis and downregulated by TNF blockade in spondyloarthropathy. Arthritis Rheum (in press)

    Google Scholar 

  44. Ritchlin CT, et al. (2003) Mechanisms of TNF-alpha and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111: 821–831

    Article  PubMed  CAS  Google Scholar 

  45. Suda T, et al. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345–357

    Article  PubMed  CAS  Google Scholar 

  46. Lacey DL, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165–176

    Article  PubMed  CAS  Google Scholar 

  47. Hofbauer LC, Heufelder AE (2001) The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum 44: 253–259

    Article  PubMed  CAS  Google Scholar 

  48. Udagawa N, et al. (2002) The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 4: 281–289

    Article  PubMed  CAS  Google Scholar 

  49. Braun J, et al. (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38: 499–505

    PubMed  CAS  Google Scholar 

  50. Peng H, et al. (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751–759

    Article  PubMed  CAS  Google Scholar 

  51. Stankler L (1969) An experimental investigation on the site of skin damage inducing the Koebner reaction in psoriasis. Br J Dermatol 81: 534–535

    PubMed  CAS  Google Scholar 

  52. Melski JW, Bernhard JD, Stern RS (1983) The Koebner (isomorphic) response in psoriasis. Associations with early age at onset and multiple previous therapies. Arch Dermatol 119: 655–659

    Article  PubMed  CAS  Google Scholar 

  53. Langevitz P, Buskila D, Gladman DD (1990) Psoriatic arthritis precipitated by physical trauma. J Rheumatol 17: 695–697

    PubMed  CAS  Google Scholar 

  54. Rasmussen JE (2000) The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis. Pediatr Infect Dis J 19: 153–154

    PubMed  CAS  Google Scholar 

  55. Rahman MU, et al. (1990) High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides. J Rheumatol 17: 621–655

    PubMed  CAS  Google Scholar 

  56. Vasey FB, et al. (1982) Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 9: 719–722

    PubMed  CAS  Google Scholar 

  57. Leung DY, et al. (1995) Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 96: 2106–2112

    Article  PubMed  CAS  Google Scholar 

  58. Travers JB, et al. (1999) Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis [comment]. J Clin Invest 104: 1181–1189

    PubMed  CAS  Google Scholar 

  59. Arnett FC, Reveille JD, Duvic M (1991) Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am 17: 59–78

    PubMed  CAS  Google Scholar 

  60. Brancato L, et al. (1989) Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter’s syndrome and related disorders associated with HIV infection. Rheumatol Int 9: 137–141

    PubMed  CAS  Google Scholar 

  61. Mijiyawa M, Oniankitan O, Khan MA (2000) Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 12: 281–286

    Article  PubMed  CAS  Google Scholar 

  62. Njobvu P, McGill P (2000) Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 27: 1699–1702

    PubMed  CAS  Google Scholar 

  63. Bardos T, et al. (2002) Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age. Arthritis Rheum 46: 2465–2475

    PubMed  CAS  Google Scholar 

  64. Nickoloff BJ (2000) The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model. Cutis 65: 110–114

    PubMed  CAS  Google Scholar 

  65. Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155: 145–158

    PubMed  CAS  Google Scholar 

  66. Hong K, et al. (1999) IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J Immunol 162: 7480–7491

    PubMed  CAS  Google Scholar 

  67. Khare SD, Luthra HS, David CS (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 182: 1153–1158

    Article  PubMed  CAS  Google Scholar 

  68. Rothschild BM, Woods RJ (1989) Spondyloarthropathy in gorillas. Semin Arthritis Rheum 18: 267–276

    Article  PubMed  CAS  Google Scholar 

  69. Rothschild BM, Woods RJ (1992) Erosive arthritis and spondyloarthropathy in Old World primates. Am J Phys Anthropol 88: 389–400

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Rochester Medical Center, Rochester, NY, USA

    Jennifer Barton MD

  2. Allergy Immunology Rheumatology, University of Rochester Medical Center, Rochester, NY, USA

    Christopher T. Ritchlin MD

Authors
  1. Jennifer Barton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher T. Ritchlin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Dermatology, Loyola University, Stritch School of Medicine, 2160 S. First Ave., Building 112, Room 342, Maywood, IL, 60153, USA

    Kenneth B. Gordon MD

  2. Division of Rheumatology, Northwestern University, Feinberg School of Medicine, 675 N. St. Clair St., Chicago, IL, 60611, USA

    Eric M. Ruderman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Barton, J., Ritchlin, C.T. (2005). Psoriatic Arthritis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_5

Download citation

  • DOI: https://doi.org/10.1007/3-540-27190-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21280-5

  • Online ISBN: 978-3-540-27190-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation